Target intelligence / Profile preview

SCO2 cytochrome c oxidase assembly protein (SCO2)

Target
SCO2
Molecular classification
Mitochondrial protein assembly factor, Copper metallochaperone, Enzyme chaperone, Other
01

Overview

SCO2 cytochrome c oxidase assembly protein (SCO2) is a mitochondrial metallochaperone essential for the assembly of cytochrome c oxidase (Complex IV) in the mitochondrial respiratory chain[1][2]. It specifically mediates delivery of copper ions to the CuA site of cytochrome c oxidase subunit II, working alongside SCO1 and interacting with additional assembly factors[1][2][3]. SCO2 also acts as a thiol-disulfide oxidoreductase during later stages of assembly, thereby regulating cysteine residues and facilitating correct maturation and enzymatic activity of Complex IV[1][2]. Dysfunction (largely due to mutations) in SCO2 impairs mitochondrial respiration, leading to tissue-specific deficiencies in oxidative phosphorylation, which manifest clinically as severe neuromuscular, cardiac, or ocular syndromes[1][2]. Recent evidence supports roles for SCO2 in metabolic regulation and as a possible cancer biomarker, owing to its linkage with p53-regulated metabolic switching and prognostic significance in multiple tumor types[2].

Other names
SCO2 homolog, mitochondrialSCO cytochrome oxidase deficient homolog 2CEMCOX1MYP6SCO1L
02

Mechanism of action

Supplementation with copper rescues cytochrome c oxidase function in cells with SCO2 mutations[2] Potential future targeting: enhancement of copper delivery, or modulation of redox-regulating chaperone activity[2]

03

Biological functions

Cytochrome c oxidase assembly (Complex IV of electron transport chain)Copper ion delivery (to COX subunit II)Thioldisulfide oxidoreductase activityMitochondrial oxidative phosphorylation regulationRedox regulationCellular metabolic regulation (impacts shift between glycolysis and oxidative phosphorylation)
04

Disease associations

Mitochondrial diseases: Fatal infantile cardioencephalomyopathy, Leigh syndrome, Myopia 6NeurodegenerationCancer (prognostic roles in glioblastoma, gastric cancer, lung adenocarcinoma)Metabolic syndromes/mitochondrial defects
05

Safety considerations

General toxicity risk of copper supplementationOff-target metabolic disturbance (if modulating mitochondrial copper pathway)Complex, tissue-specific disease presentations in genetic disorders[2]Mitochondrial toxicity in potential future therapies
06

Interacting drugs

Copper supplementation (as a metabolic therapy in mutation cases)
07

Biomarkers

SCO2 gene/protein abundance and mutation as a biomarker for mitochondrial disordersSCO2 expression as a possible prognostic biomarker in certain cancers[2]

Beyond the preview

Go deeper on SCO2 cytochrome c oxidase assembly protein (SCO2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SCO2 cytochrome c oxidase assembly protein (SCO2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call